Earnings release
Page 1
Press release - Regulated Information Melexis Q3 2026 results – Third quarter sales of 223.7 million EUR Intermediate declaration by the Board of Directors Ieper, Belgium – October 28th, 2026, 07.00 hrs CET CONFORM IFRS Q3 2026 Q3 2025 YOY change Q2 2026 SEQ change in k EUR (%) (%) Sales 223,714 215,287 4% 217,058 3% Gross result 91,081 83,425 9% 87,939 4% Gross Margin 40.7% 38.8% 40.5% EBIT 41,293 37,845 9% 38,571 7% EBIT in % 18.5% 17.6% 17.8% EBITDA 54,180 51,397 5% 51,894 4% EBITDA in % 24.2% 23.9% 23.9% Net result 31,324 27,528 14% 30,776 2% Net result per share (EPS) 0.78 0.68 0.76 CAPEX 8,350 5,319 10,464 Sales for the third quarter of 2026 were 223.7 million EUR, an increase of 4% compared to the same quarter of the previous year and an increase of 3% compared to the previous quarter. The EUR/USD exchange rate evolution had a positive impact of 1% on sales compared to the same quarter of last year and no impact on sales compared to the previous quarter. The gross result was 91.1 million EUR or 40.7% of sales, an increase of 9% compared to the same quarter of last year and an increase of 4% compared to the previous quarter. R&D expenses were 13.6% of sales, G&A was at 6.5% of sales and Selling was at 2.2% of sales. The operating result was 41.3 million EUR or 18.5% of sales, an increase of 9% compared to the same quarter of last year and an increase of 7% compared to the previous quarter. The net result was 31.3 million EUR or 0.78 EUR per share, an increase of 14% compared to 27.5 million EUR or 0.68 EUR per share in the third quarter of 2025 and an increase of 2% compared to the previous quarter. 1 Melexis Financial Press Release Regulated Information
Page 2
CONFORM IFRS 9M 2026 9M 2025 YOY change in k EUR (%) Sales 642,867 625,124 3% Gross result 259,630 241,707 7% Gross Margin 40.4% 38.7% EBIT 113,037 102,479 10% EBIT in % 17.6% 16.4% EBITDA 151,838 142,740 6% EBITDA in % 23.6% 22.8% Net result 85,194 89,931 -5% Net result per share (EPS) 2.11 2.23 CAPEX 28,361 21,673 Sales for the first nine months of 2026 were 642.9 million EUR, an increase of 3% compared to the first nine months of 2025. The EUR/USD exchange rate evolution had a negative impact of 1% on sales compared to the first nine months of 2025. The gross result was 259.6 million EUR or 40.4% of sales, an increase of 7% compared to the same period last year. R&D expenses were 13.9% of sales, G&A was at 6.7% of sales and Selling was at 2.2% of sales. The operating result was 113.0 million EUR or 17.6% of sales, an increase of 10% compared to 102.5 million EUR in the same nine months of 2025. The net result was 85.2 million EUR or 2.11 EUR per share, a decrease of 5% compared to 89.9 million EUR or 2.23 EUR per share in the first nine months of 2025. Outlook Melexis confirms its second half 2026 outlook, which is for sales to be between 445 and 455 million EUR, with a gross profit margin around 41% and an operating margin around 18%, all taking into account a EUR/ USD exchange rate of 1.12 for the remainder of the year. For the full year 2026, Melexis expects CAPEX to be around 40 million EUR. 2 Melexis Financial Press Release Regulated Information
Page 3
Quote from CEO Marc Biron "Our results in the third quarter of 2026 were in line with expectations. Now that customers have normalized their inventories, automotive demand is clearly growing driven by greater content, and we are gaining new business in targeted applications. Thanks to disciplined cost management, gross margins are up 170 basis points year-on-year in the first nine months. We made further progress with our strategy to win in high-growth markets. In China, we signed a Master Purchase Agreement with BYD, a leading OEM. We also announced a new current sensor, our first integrated circuit (IC) produced through a localized manufacturing model in China, demonstrating our commitment to match customers' requirements. Our Q3 sales in China were the highest ever, with Q4 2026 orders pointing to a further increase. In India, we opened a new office in Pune, to build our local team and accelerate sales growth. Our robotics technology is now powering active customer production earlier than expected. Q3 marks a milestone quarter where design wins have successfully translated into volume ramps, cementing our position as a leading solution supplier of physical AI. Q3 demonstrates that our strategic choices are delivering tangible results. While maintaining cost discipline, we continue to drive a high rate of product releases to capture new business in our chosen growth areas." 3 Melexis Financial Press Release Regulated Information
Page 4
Financial Calendar - Publication FY 2026 Results: February 3, 2027 (at 7 hrs CET) - Publication Q1 2027 Results: April 28, 2027 (at 7 hrs CET) - Publication Q2 2027 Results: July 28, 2027 (at 7 hrs CET) - Publication Q3 2027 Results: October 27, 2027 (at 7 hrs CET) - Publication FY 2027 Results: February 2, 2028 (at 7 hrs CET) The company’s results will be discussed in English in an audio webcast and conference call on Wednesday, October 28th, 2026 at 10:30 hrs CET. Joining this event requires registration in advance. To register for the audio webcast (no possibility to ask questions) You can register for the audio webcast by clicking here. To register for the conference call (possibility to ask questions) You can register by clicking here and filling out the requested information. After registration, you will receive the conference call number, a participant user pin, conference pin and instructions on how to join the conference call. For security purposes, all participants must register individually if they wish to join the call. For more information: Investors Investor Relations Email: investor@melexis.com Journalists Brand & Communications Email: brandcomms@melexis.com About Melexis Melexis designs, develops, and delivers edge sensor and driver solutions with a heart for people and planet. Its mission is to empower engineers to turn their ideas into applications that support the best imaginable future, one that is safe, comfortable and sustainable. Melexis specializes in powertrain, thermal management, lighting, e-brake, e-steering and battery solutions for the automotive sector. It also expands its presence in the emerging markets of sustainable world, alternative mobility, robotics, and digital health. Founded in 1989 in Belgium, Melexis has grown to employ around 2,000 people in 12 countries, delivering cutting-edge technology to customers worldwide. For more information, visit www.melexis.com or follow Melexis on LinkedIn, and YouTube. 4 Melexis Financial Press Release Regulated Information
Page 5
Disclaimer Except for those statements that report the Company's historical results, the statements being made are forward looking statements. Actual results could differ materially from those projected in the forward- looking statements. Factors which could cause actual results to differ from expectations include the following: volatility in supply and demand affecting revenues and market prices, price and availability of silicon foundry, assembly and test prices, assembly and test subcontract capacity required to meet financial targets and/or meet backlog requirements, risks and delays associated with bringing up new production capabilities or with deliveries from subcontractors, timing and market acceptance of new products, increased expenses associated with new product acceptance of new products, increased expenses associated with new product introductions of process changes, delays in developing or achieving volume production of new products, which can result in delays or failure to contribute to revenues and profits, ability of the Company to maintain its customer and vendor base and delays in and/or inability in raising additional capital. 5 Melexis Financial Press Release Regulated Information
Page 6
Consolidated income statement CONFORM IFRS Quarter ended Quarter ended Nine months ended Nine months ended Year ended 30/9/2026 30/9/2025 30/9/2026 30/9/2025 31/12/2025 in k EUR audited Sales 223,714 215,287 642,867 625,124 839,617 Cost of sales -132,633 -131,862 -383,237 -383,417 -515,608 Gross result 91,081 83,425 259,630 241,707 324,009 R&D -30,334 -27,548 -89,589 -84,784 -115,897 G&A -14,516 -13,126 -42,808 -39,899 -54,332 Selling -4,938 -4,905 -14,196 -14,544 -19,818 Operating result (EBIT) 41,293 37,845 113,037 102,479 133,963 Financial result -2,677 -3,013 -10,129 4,900 1,932 Result before taxes 38,615 34,832 102,909 107,379 135,895 Income taxes -7,291 -7,304 -17,715 -17,448 -23,390 Net result 31,324 27,528 85,194 89,931 112,505 Net result per share in EUR 0.78 0.68 2.11 2.23 2.78 Consolidated statement of financial position CONFORM IFRS Nine months ended Nine months ended Year ended 30/9/2026 30/9/2025 31/12/2025 in k EUR audited Current Assets : Cash and cash equivalents 37,380 33,321 34,633 Current investments — 404 — A/R Trade 119,329 106,768 107,852 Assets for current tax 13,474 29,201 27,727 Other current assets 104,273 106,775 108,805 Inventories 261,529 299,095 300,329 Total current assets 535,984 575,564 579,347 Non-current assets : Property, plant and equipment 189,288 199,429 196,956 Leased assets 8,088 7,875 7,583 Intangible fixed assets 1,375 1,329 1,197 Other non-current assets 28,624 102,266 82,819 Deferred tax assets 34,365 35,109 35,367 Total non-current assets 261,741 346,008 323,922 Total assets 797,725 921,571 903,269 6 Melexis Financial Press Release Regulated Information
Page 7
CONFORM IFRS Nine months ended Nine months ended Year ended 30/9/2026 30/9/2025 31/12/2025 in k EUR audited Current liabilities : Derivative financial instruments 178 — 284 Current portion of LT debt 3,112 12,166 13,022 Lease liabilities 957 936 2,116 A/P trade 40,204 54,490 51,054 Accrued taxes 8,496 5,905 6,706 Short-term employee benefits accruals 28,141 24,486 22,523 Other current liabilities 8,570 5,955 5,902 Deferred income 2,856 4,066 4,445 Total current liabilities 92,514 108,004 106,052 Non current liabilities : LT debt less current portion 227,266 265,779 301,278 Lease liabilities 7,316 7,073 5,623 Deferred tax liabilities 2,951 2,344 2,673 Other non-current liabilities 3,115 3,675 3,115 Total non current liabilities 240,648 278,871 312,688 Shareholders' equity : Shareholders' capital 565 565 565 Treasury shares -61,682 -28,754 -50,031 Legal reserve 57 57 57 Retained earnings 445,159 478,630 427,102 Current period's profit 85,194 89,931 112,505 Cumulative translation adjustment -4,729 -5,732 -5,669 Equity attributable to company owners 464,563 534,696 484,529 Non controlling interests — — — Total shareholders equity 464,563 534,696 484,529 Total liabilities, shareholders' equity and minority interests 797,725 921,571 903,269 7 Melexis Financial Press Release Regulated Information
Page 8
Consolidated statement of cash flows CONFORM IFRS Quarter ended Quarter ended Nine months ended Nine months ended Year ended 30/9/2026 30/9/2025 30/9/2026 30/9/2025 31/12/2025 in k EUR audited Cash flow from operating activities Net income 31,324 27,528 85,194 89,931 112,505 Adjustments for : — Operating activities 22,234 24,009 61,431 63,092 85,266 Depreciation and amortisation 12,219 12,980 37,066 38,557 51,034 Depreciation leased assets 668 572 1,735 1,704 2,305 Other provisions — 200 — -892 -991 Deferred income -6 994 -1,589 1,990 2,369 Financial result 2,062 1,958 6,504 4,285 7,160 Income tax expense/income 7,291 7,304 17,715 17,448 23,390 Operating profit before working capital changes 53,558 51,537 146,624 153,023 197,771 A/R, Trade 3,699 -1,940 -10,962 -4,982 -6,063 Other current assets -1,809 -7,265 4,532 -50,814 -52,844 Other non current assets 16,128 19,103 54,195 61,315 80,762 Inventories 7,734 -13,857 34,831 -41,945 -44,585 A/P -9,226 -4,584 -10,851 -8,712 -12,149 Employee benefit liabilities 4,631 3,769 5,563 6,247 4,307 Other current liabilities 2,500 1,387 2,668 -3,365 -3,418 Cash generated from operations 77,214 48,150 226,600 110,767 163,781 Interest paid -2,051 -2,146 -5,967 -7,008 -9,262 Income tax paid -2,686 -1,504 -355 -24,473 -28,213 Cash flow from operating activities 72,477 44,500 220,278 79,286 126,306 Cash flow from investing activities Purchase of PPE and intangible assets (netted) -6,782 -7,454 -26,120 -20,896 -29,364 Interest received 55 3 158 118 178 Cash provided from investing activities -6,727 -7,451 -25,962 -20,777 -29,185 Cash flows from financing activities Proceeds/Repayment of long-and short-term debt -62,809 -36,036 -83,921 64,622 100,977 Repayment leasings -599 -544 -1,706 -1,626 -2,206 Dividend payment — — -94,448 -95,976 -147,851 Acquisition own shares -2,465 -1,033 -11,651 -24,344 -45,621 Cash provided from financing activities -65,873 -37,614 -191,726 -57,323 -94,699 Effect of exchange rate changes on cash and cash equivalents 156 -26 157 -545 -469 Increase/decrease in cash and cash equivalents 32 -590 2,747 640 1,952 Cash at beginning of the period 37,348 33,912 34,633 32,681 32,681 Cash at the end of the period 37,380 33,321 37,380 33,321 34,633 8 Melexis Financial Press Release Regulated Information
Page 9
Sales per Geography Q3 2026 Q3 2025 9M 2026 9M 2025 FY 2025 APAC 65% 61% 62% 62% 64% Asia Pacific EMEA 27% 31% 30% 29% 28% Europe - Middle-East - Africa NALA 8% 8% 8% 8% 8% North America - Latin America TOTAL 100% 100% 100% 100% 100% 9 Melexis Financial Press Release Regulated Information